Digitalis Glycosides in Patients With Heart Failure
To the Editor A recent meta-analysis of 3 large placebo-controlled randomized clinical trials suggested a lower risk of cardiovascular death or first worsening heart failure (HF) event in patients with HF who were treated with digitalis glycosides. However, several important limitations warrant particular consideration.
We haven't written up this one. JAMA has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Digitalis Glycosides in Patients With Heart Failure—Reply jamanetwork.com
